Eecp Center of Rochester Rochester, MI - 48307

Eecp Center of Rochester is categorized under Internal Medicine Doctors in Rochester, MI and active since 2003.

Eecp Center of Rochester was established in 2003, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Judy Harder at the company’s single location by writing to 543 North Main St, Rochester, Michigan MI 48307 or by phoning (248) 601-7711. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Eecp Center of Rochester
Contact Person: Judy Harder
Address: 543 North Main St, Rochester, Michigan 48307
Phone Number: (248) 601-7711
Website Address: rochestermedicalcenter.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Eecp Center of Rochester was started in 2003 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Judy Harder for inquiries that concern Eecp Center of Rochester by calling the company number (248) 601-7711, as your correspondence is most welcome. Additionally, the physical location of the single location of Eecp Center of Rochester can be found at the coordinates 42.68307,-83.13391 as well as the street address 543 North Main St in Rochester, Michigan 48307.

For its online presence, you may visit Eecp Center of Rochester’s website at rochestermedicalcenter.com and engage with its social media outlets through on Twitter and on Facebook.